Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Sugarman

Showing results (71-80 of 82) with videos related to

Pageof 9
Sort By:
JAMA Ophthalmology|January 27, 2017
Clinical Features Differentiating Benign From Malignant Conjunctival Tumors in ChildrenCarol L Shields, Kareem Sioufi, Adel E Alset, et al.
American Journal of Ophthalmology|October 12, 2016
Conjunctival Tumors in 5002 Cases. Comparative Analysis of Benign Versus Malignant Counterparts. The 2016 James D. Allen LectureCarol L Shields, Adel E Alset, Nina S Boal, et al.
Alzheimer'S Research & Therapy|July 29, 2019
Independent effects of white matter hyperintensities on cognitive, neuropsychiatric, and functional decline: a longitudinal investigation using the National Alzheimer's Coordinating Center Uniform Data SetChristian Puzo, Caroline Labriola, Michael A Sugarman, et al.
Journal of Alzheimer'S Disease : JAD|May 31, 2018
A Clinicopathological Investigation of White Matter Hyperintensities and Alzheimer's Disease NeuropathologyMichael L Alosco, Michael A Sugarman, Lilah M Besser, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 11, 2019
Failure to detect an association between self-reported traumatic brain injury and Alzheimer's disease neuropathology and dementiaMichael A Sugarman, Ann C McKee, Thor D Stein, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|September 3, 2010
Carrier testing for spinal muscular atrophyJonathan M Gitlin, Kenneth Fischbeck, Thomas O Crawford, et al.
Neurobiology of Aging|June 26, 2020
A longitudinal examination of plasma neurofilament light and total tau for the clinical detection and monitoring of Alzheimer's diseaseMichael A Sugarman, Henrik Zetterberg, Kaj Blennow, et al.
Brain : a Journal of Neurology|May 13, 2022
Ante-mortem plasma phosphorylated tau (181) predicts Alzheimer's disease neuropathology and regional tau at autopsyMadeline S Morrison, Hugo J Aparicio, Kaj Blennow, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 2, 2021
Plasma p-tau<sub>181</sub> shows stronger network association to Alzheimer's disease dementia than neurofilament light and total tauBrandon Frank, Madeline Ally, Bailee Brekke, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|October 27, 2023
Cross-sectional and longitudinal evaluation of plasma glial fibrillary acidic protein to detect and predict clinical syndromes of Alzheimer's diseaseMadeline Ally, Michael A Sugarman, Henrik Zetterberg, et al.
Pageof 9

Showing results (71-80 of 82) with videos related to

Sort By:
Pageof 9
JAMA Ophthalmology|January 27, 2017
Clinical Features Differentiating Benign From Malignant Conjunctival Tumors in ChildrenCarol L Shields, Kareem Sioufi, Adel E Alset, et al.
American Journal of Ophthalmology|October 12, 2016
Conjunctival Tumors in 5002 Cases. Comparative Analysis of Benign Versus Malignant Counterparts. The 2016 James D. Allen LectureCarol L Shields, Adel E Alset, Nina S Boal, et al.
Alzheimer'S Research & Therapy|July 29, 2019
Independent effects of white matter hyperintensities on cognitive, neuropsychiatric, and functional decline: a longitudinal investigation using the National Alzheimer's Coordinating Center Uniform Data SetChristian Puzo, Caroline Labriola, Michael A Sugarman, et al.
Journal of Alzheimer'S Disease : JAD|May 31, 2018
A Clinicopathological Investigation of White Matter Hyperintensities and Alzheimer's Disease NeuropathologyMichael L Alosco, Michael A Sugarman, Lilah M Besser, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 11, 2019
Failure to detect an association between self-reported traumatic brain injury and Alzheimer's disease neuropathology and dementiaMichael A Sugarman, Ann C McKee, Thor D Stein, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|September 3, 2010
Carrier testing for spinal muscular atrophyJonathan M Gitlin, Kenneth Fischbeck, Thomas O Crawford, et al.
Neurobiology of Aging|June 26, 2020
A longitudinal examination of plasma neurofilament light and total tau for the clinical detection and monitoring of Alzheimer's diseaseMichael A Sugarman, Henrik Zetterberg, Kaj Blennow, et al.
Brain : a Journal of Neurology|May 13, 2022
Ante-mortem plasma phosphorylated tau (181) predicts Alzheimer's disease neuropathology and regional tau at autopsyMadeline S Morrison, Hugo J Aparicio, Kaj Blennow, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 2, 2021
Plasma p-tau<sub>181</sub> shows stronger network association to Alzheimer's disease dementia than neurofilament light and total tauBrandon Frank, Madeline Ally, Bailee Brekke, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|October 27, 2023
Cross-sectional and longitudinal evaluation of plasma glial fibrillary acidic protein to detect and predict clinical syndromes of Alzheimer's diseaseMadeline Ally, Michael A Sugarman, Henrik Zetterberg, et al.
Pageof 9